Psilocybin Behavioral Health Access and Therapy Pilot Program established; $6 million appropriated.
New Jersey A3852, the "Psilocybin Behavioral Health Access and Services Act," establishes a regulatory framework for the production and use of psilocybin for behavioral health care and preventative treatment. The bill decriminalizes psilocybin for individuals over 21 and expunges past offenses related to psilocybin conduct authorized by the act. It creates a pilot program for psilocybin services, including licensing requirements for manufacturers, service centers, and facilitators.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.